Tyra Biosciences, Inc. (NASDAQ:TYRA) has 130 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 12,198,625 | 0 | 0.00% | $320,701,851.00 |
| Nextech Invest, Ltd. | 31 Dec, 2025 | 4,055,861 | 0 | 0.00% | $106,628,586.00 |
| Alta Partners Management Company, L.P. | 31 Dec, 2025 | 3,823,425 | -256,871 | -6.30% | $100,517,843.00 |
| Commodore Capital LP | 31 Dec, 2025 | 3,375,000 | 0 | 0.00% | $88,728,750.00 |
| Canaan Partners XI LLC | 31 Dec, 2025 | 3,374,329 | -233,780 | -6.48% | $88,711,109.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 2,935,442 | 60,638 | 2.11% | $77,084,707.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 2,898,103 | 0 | 0.00% | $76,191,128.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 2,425,000 | 0 | 0.00% | $63,753,250.00 |
| BVF INC/IL | 31 Dec, 2025 | 2,127,665 | -1,522,129 | -41.70% | $55,936,313.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 2,086,423 | 216,949 | 11.60% | $54,852,060.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 2,066,818 | -220,818 | -9.65% | $54,336,645.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,572,785 | 52,600 | 3.46% | $41,348,518.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 1,564,492 | -765,506 | -32.85% | $41,130,495.00 |
| 5AM Venture Management, LLC | 31 Dec, 2025 | 1,029,298 | 90,000 | 9.58% | $27,060,244.00 |
| Caligan Partners LP | 31 Dec, 2025 | 944,257 | 247,432 | 35.51% | $24,824,517.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 874,192 | 592,160 | 209.96% | $22,982,508.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 818,326 | -28,259 | -3.34% | $21,513,791.00 |
| State Street Corp | 31 Dec, 2025 | 749,463 | 320,991 | 74.92% | $19,703,382.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 711,891 | 109,876 | 18.25% | $18,715,614.00 |
| Trails Edge Capital Partners, LP | 31 Dec, 2025 | 700,000 | 700,000 | 0.00% | $18,403,000.00 |